Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of Gentex Corporation
-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We lower our 12-month target by $2 to $30, based on a 2027 P/E of 13.3x, a justified discount to GNTX's five-year average P/E of 16.7x. We maintain our EPS estimates of $2.00 for 2026 and $2.25 for 2027. Following GNTX's Q1 earnings release, we are lowering our price target but reiterating our Strong Buy opinion on the shares. It was a solid earnings release all around, with both sales and margins exceeding expectations and higher full-year revenue guidance. The investment thesis from our late January upgrade to Strong Buy appears intact, with gross margins rebounding nicely (+60 bps to 33.8% in Q1) and a risk/reward that appears compelling. While tepid volumes remain a concern (mirror shipments were -6%), GNTX's strong balance sheet and sub-industry leading gross margins are key distinguishing factors supporting our rating. GNTX's 12% Y/Y EPS growth in Q1 also underscores its easier near-term comps.